Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency

European Journal of Haematology, EarlyView.
Source: European Journal of Haematology - Category: Hematology Authors: Source Type: research